Frank Aaretrup (Copenhagen, Denmark)
Frank Aaretrup is Professor, Head of Research Group at the Danish Technical Institute (DTU) in Copenhagen, Denmark. His research has primarily targeted the association between use of antimicrobial agents to farm animals and the emergence and spread of antimicrobial resistance including the human health consequences. He has now focused on the genomic and metagenomic fields, especially with respect to the antibiotic resistance typing. He has co-authored more than 400 papers.
Peer Bork (Heidelberg, Germany)
Peer Bork is group leader, senior scientist and joint head of the Structural and Computational Biology unit at EMBL. He works in various areas of computational biology and systems analysis with a focus on function prediction, comparative analysis and data integration. He is a worldwide leader in the field of metagenomics of the intestinal microbiota. He coauthored more than 600 research articles in international, peer-reviewed journals, among them more than 50 in Nature, Science and Cell.
Judith Breuer (London, UK)
Judith Breuer is professor of Virology at the Faculty of Medical Sciences of London. Her research at the MCR-UCL Centre for Molecular Virology has resulted in the successful development of methodologies to recover low copy viral DNA from clinical samples and subsequent generation of template suitable for whole genome sequencing, including the detection
of rare variants. She is currently applying these methods to investigate the genetic association of Varicella zoster (VZV) and Herpes Simplex Virus (HSV) with different disease states. Other research interests include genetic variation of alpha HSV and pathogenesis in skin tissue, and broader molecular diagnostic tools in viral disease.
Patrick Wincker (Evry, France)
Patrick Wincker has been the director of the sequencing technology and eukaryote genomics groups at Genoscope in Evry, France since 1997. He is coordinating the use of sequencing and bioinformatics technologies to assemble and analyse complex genomes and metagenomes. He is since 2009 one of the scientific coordinators of the Tara Oceans program. In this frame, he is developing meta-omics methods to study complex eukaryotic communities in ocean plankton.
George Weinstock (Farmington, CT, US)
GW is one of the leaders of the Human Microbiome Project, an international effort to apply and develop the latest technologies to comprehensively characterize the microbiome and its impact on human health. While not addressing brain diseases, the unprecedented insight on the normal composition of the human GMB is instrumental to study its relationship with neurodegenerative diseases.
Jérôme Bouquet (San Francisco, CA, US)
Dr. Jerome Bouquet is a postdoctoral scholar in Dr. Charles Chiu’s lab at UCSF, San Francisco, USA, specialized in clinical metagenomics and human transcriptomics to develop the next generation of diagnostics for infectious diseases. His work focuses on the identification of known or novel pathogens in idiopathic cases by next generation sequencing, and human biomarker discovery in Lyme disease, Ebola virus and Zika virus infections. He earned his PhD from the University Pierre and Marie Curie, Paris, France, studying genomes and quasispecies of hepatitis E virus to explore its zoonotic potential from swine to human. He is the recipient of the 2014 Emerging leader award from the Bay Area Lyme foundation.
Christopher Ford (Cambridge, MA, USA)
Christopher Ford is a senior scientist who recently joined Seres Therapeutics, Inc. ("Seres"). He previously worked at the Broad Institute where he studied pathogenesis of Candida albicans. He then moved to Harvard School of Public Health where he studied the evolution of drug resistance in Mycobacterium tuberculosis.
Derrick Crook (Oxford, UK)
David Cook is the Executive Vice President of R&D and Chief Scientific Officer of Seres Therapeutics, Inc. ("Seres"). He has over 20 years of experience as a scientist and entrepreneur and has held senior operating and management positions in the biotechnology industry throughout his career. He is also a co-inventor on more than 25 patents.
Joe DeRisi (San Francisco, CA, US)
Joe Derisi is professor at the UCSF School of Medicine. He work focuses on whole genome approaches to tackle problems in yeast molecular biology and human infectious diseases. His lab is involved in the development of algorithms for metagenomic data and their application for clinical purposes.
Dusko Ehrlich (Jouy-en-Josas, France)
Stanislav Dusko EHRLICH was trained in Organic Chemistry at the University of Zagreb, Croatia and obtained PhD degree in Biochemistry at the University Paris VII, France. He was a research associate of Dr. Joshua Lederberg, Nobel Prize winner, in the Department of Genetics, Stanford University Medical School, California. He founded and directed Microbial
Genetics Research Unit and the Microbiology Department at the National Institute for Agricultural Research (INRA). He also founded a start-up company Enterome, developing microbiome-based biomarkers. He is Research Director Emeritus at INRA, Professor at King’s College London and Chief Scientific Officer of Enterome. His research interests are in
Human Microbiome; he coordinated the EU-funded project MetaHIT and is the PI of the French Government Investissement d’Avenir 19 M€ grant MetaGenopolis.
Marc Eloit (Paris, France)
Marc Eloit is professor of virology and head of the laboratory of pathogen discovery at the Institut Pasteur in Paris, France. He is also the scientific founder of Pathoquest, a pioneer, spin-off company of Institut Pasteur dedicated to clinical metagenomics
Nick Loman (Oxford, UK)
Nick Loman works as an Independent Research Fellow in the Institute for Microbiology and Infection at the University of Birmingham, sponsored by an MRC Fellowship in Biomedical Informatics. His research explores the use of cutting-edge genomics and metagenomics approaches to the diagnosis, treatment and surveillance of infectious disease. Nick has so
far used high-throughput sequencing to investigate outbreaks of important pathogens such as Pseudomonas aeruginosa,Acinetobacter baumannii and Shiga-toxin producing Escherichia coli. His current work focuses on the application of novel sequencing technologies such as the Oxford Nanopore for genome diagnosis and epidemiology of important pathogens. A more general aim is to develop bioinformatics tools to aid the interpretation of genome and metagenome-scale data in routine clinical practice in collaboration..
Eric Pamer (New York, NY, US)
Eric G. Pamer received his MD degree from Case Western Reserve University Medical School and completed clinical training in Internal Medicine and Infectious Diseases at UCSD Medical Center. He was a postdoctoral fellow with Charles E. Davis at UCSD, Maggie So at Scripps Research Institute and Michael Bevan at the University of Washington and then moved to Yale University. In 2000 he moved his laboratory to Memorial Sloan-Kettering Cancer Center in New York where he a Member of the Infectious Diseases Service, Head of the Division of Medical Subspecialties and Director of the Center for Microbes, Inflammation and Cancer
Cynthia Sears (Baltimore, MD, USA)
Cynthia Sears (MD) is an infectious diseases specialist from the John hopkins Hospital, Baltimore, USA. Her laboratory focuses on the pathogenesis of colon disease by enteric bacteria using enterotoxigenic Bacteroides fragilis (ETBF) as a model for inducing colon inflammation. She identified the B. fragilis toxin gene (bft), purified the protein (BFT) and defined its mechanism of action in vitro. More recently, she established in vivo models of ETBF colitis and colon tumorigenesis. Using these models, she has identified that ETBF induces selective Stat3/Th17 immune responses in the colon and that these pathways, at least in part, contribute to colon tumorigenesis. Her data were the first to report this mechanism for inflammation-induced endogenous colon tumor induction in response to colon colonization with a human commensal (up to 40% of ETBF-colonized humans are asymptomatic). She is extending this work to human studies to understand the microbial contribution to colitis and colon cancer pathogenesis.
Stylianos Antonarakis (Geneva, Switzerland)
Stylianos Antonarakis is Professor and Chairman of Genetic Medicine at the University of Geneva Medical School, and director of the iGE3 institute of Genetics and Genomics in Geneva, Switzerland. He is the President of the Human Genome Organization (since 2013), a member of the scientific council of the Swiss National Science Foundation, and chair of the Genetics panel of the European Research Council. Previously he was the President of the European Society of Human Genetics. His research focuses on the relationship between genomic and phenotypic variations, in particular the functional analysis of the genome, effect of human genetic variation to phenotypic variation, the molecular pathogenesis of trisomy 21 and polygenic phenotypes, the functional characterization of the conserved fraction of the genome, diagnostics and prevention of genetic disorders, and the societal implications of genetics and genome research. Antonarakis coauthored more than 620 papers and is listed as one of the highly cited scientists by the Institute for Scientific Information (h-index 94).
Gilbert Greub (Lausanne, Switzerland)
Gilbert Greub(MD, PhD) heads the microbiology laboratory at the Vaud University Hospital and the Institute of Microbiology in Lausanne. His research focuses on the discovery of new pathogens and those for which are unculturable. In this perspective, he has a strong experience in molecular tools, especially genomics and metagenomics.
Etienne Ruppé (Geneva, Switzerland)
Etienne Ruppé (PharmD, PhD) is a clinical microbiologist. After graduation in 2008, he spent 4 years as an assistant in the bacteriology laboratory of the Bichat-Claude Bernard University teaching hospital and obtained his PhD in Infectiology for his work on the epidemiology of carriage of multidrug-resistant bacteria. After a first post-doc focusing on the resistome of the human gut microbiota, he moved as research assistant in the Genomic Research Laboratory in the Geneva University Hospitals where he works on the development of clinical metagenomics .
Jacques Schrenzel (Faculty of Medicine, University of Geneva) JS is co-founder of the Center of Excellence in Bacteriology at the University of Geneva (CEBUG). He is in charge of the bacteriological laboratory and the genomic research laboratory of Geneva University Hospitals (www.genomic.ch). He is recognized for his work on bioinformatics, metagenomics, microarrays and next-generation sequencing in clinical microbiology.
With the support of: